‘Continued price growth reflects the cost increases experienced by public hospitals in recent years,’ Mr Tune added.
Key updates in the 2026–27 NEP and NEC
Clinically relevant classification updates
Admitted acute care is priced using the Australian Refined Diagnosis Related Groups Version 12.0. This includes new groupings for maternal care, organ donation after death and new principles for consistent grouping of intervention-based episodes of care.
Non-admitted services are priced using the Tier 2 Non-Admitted Services Classification Version 10.0, introducing new classes for hospital-based, non-admitted voluntary assisted dying services.
Removal of temporary Coronavirus disease 2019 (COVID-19) measures
Temporary pricing measures introduced in response to COVID-19 have been removed, as current data already reflects the pandemic’s impact.
COVID-19 will continue to be considered a risk factor in the safety and quality pricing adjustments, where statistically relevant.
Improved methodology for linking Pharmaceutical Benefits Scheme (PBS) payments to hospital activity
Under the National Health Reform Agreement, IHACPA excludes payments from other government schemes to prevent duplicate funding.
For NEP, IHAPCA has implemented an improved methodology to more accurately remove PBS benefits from its data collections, improving alignment between prices and reported cost data.
Continuation of community mental health block funding arrangements
Transitional block funding eligibility criteria for community mental health services, introduced last year, will continue in 2026–27.
Community mental health care was the first patient category to transition from block to activity-based funding, ensuring funding better reflects the volume, type and complexity of care delivered. Continuation of these criteria will support stability in the second year of the transition.
The NEP and NEC Determinations 2026–27 and supporting materials are available on IHACPA’s website.
For media enquiries contact:
E: communications.ihacpa@ihacpa.gov.au
Ph: 0402 841 279
<ENDS>